17299059Sandborn WJ, Hanauer SB, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh DG, Panaccione R, Wolf D, Kent JD, Bittle B, Li J, Pollack PFGutAnti-Inflammatory Agents; Antibodies, Monoclonal; Crohn DiseaseAdalimumab; Adult; Antibodies; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Long-Term Care; Male; Treatment OutcomeAdalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut. 2007 Sep; 56(9):1232-9.Gut2007-02-13T00:00:002007Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000328Living Beings1578255770.254432AdultD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD000893Chemicals & Drugs1513390.803694Anti-Inflammatory AgentsD007166Chemicals & Drugs2179770.66626Immunosuppressive AgentsD003424Disorders1197290.61584Crohn DiseaseD004311Procedures33818220.708936Double-Blind MethodD004359Procedures2748930.819188Drug Therapy, CombinationD008134Procedures35600.935067Long-Term CareAuthorship 314912D005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617Male0.07631030.07631031authors10.2518has subject areaD016896Concepts & Ideas101179490.402389Treatment OutcomeD061067Chemicals & Drugs2139290.656166Antibodies, Monoclonal, HumanizedD000906Chemicals & Drugs2013490.840159AntibodiesD000974Chemicals & DrugsProcedures36830.960845Antibodies, AntinuclearD00006887913800.940334AdalimumabD004334Concepts & Ideas2609160.852414Drug Administration ScheduleD007279Procedures741170.97305Injections, SubcutaneousMedicineUniversity of ChicagoStephenHanauerStephen B. Hanauer41.78927490000000-87.60125000000000660Hanauer, StephenEmeritus/Emeritatrue1Emeritus/EmeritaEmeritus/Emerita